CELECOXIB–CHALCONE HYBRIDIZATIONGENERATESDUAL COX-2/FACTOR XA INHIBITORS WITHENHANCEDCOX-2 SELECTIVITY: AN In-silico DRUGDESIGNSTUDY
RASAYAN Journal of Chemistry · 2026 · 19 (04) · 2326-2338
DOI: 10.31788/rjc.2026.1949878 ↗Kurz gefasst
Fachartikel in der Zeitschrift RASAYAN Journal of Chemistry, 2026. Verfasst von P. K. Arora und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Anti-inflammatory selective cyclooxygenase-2 (COX-2) inhibitors have minimal gastrointestinal toxicity comparedwith non-selective NSAIDs; however, cardiovascular concerns associated with selective COX-2 inhibitors highlight the need for safer anti-inflammatory agents. This study aimed to design celecoxib-based chalcone derivatives withenhanced COX-2 selectivity and potential factor Xa inhibitory activity. Fifty derivatives were rationally designedbyintroducing an α,β-unsaturated carbonyl linker between the phenyl and pyrazole rings and subjected to in-silicoevaluation using toxicity, physicochemical, ADME, and molecular docking studies against COX-2, COX-1, andanticoagulant factor (factor Xa). Of the 50 derivatives, 45 showed stronger predicted COX-2 binding than celecoxib, with reduced COX-1 interaction, while several exhibited favourable factor Xa affinity. The study has predictedleadmolecules for the development of safer anti-inflammatory therapeutics with reduced cardiovascular risk. Thus, thepresent work contributes to the advancement of multitarget drug design strategies and supports United NationsSustainable Development Goal (SDG) 3: Good Health and Well-being.
Zitieren
APA
Arora, P. K., Kumar, D., Sharma, S., Sethi, V. A., & Vaishnav, G. (2026). CELECOXIB–CHALCONE HYBRIDIZATIONGENERATESDUAL COX-2/FACTOR XA INHIBITORS WITHENHANCEDCOX-2 SELECTIVITY: AN In-silico DRUGDESIGNSTUDY. RASAYAN Journal of Chemistry, 19(04), 2326-2338. https://doi.org/10.31788/rjc.2026.1949878
Vancouver
Arora PK, Kumar D, Sharma S, Sethi VA, Vaishnav G. CELECOXIB–CHALCONE HYBRIDIZATIONGENERATESDUAL COX-2/FACTOR XA INHIBITORS WITHENHANCEDCOX-2 SELECTIVITY: AN In-silico DRUGDESIGNSTUDY. RASAYAN Journal of Chemistry. 2026;19(04):2326-2338. doi:10.31788/rjc.2026.1949878
BibTeX
@article{Arora2026,
author = {Arora, P. K. and Kumar, D. and Sharma, S. and Sethi, V. A. and Vaishnav, G.},
title = {CELECOXIB–CHALCONE HYBRIDIZATIONGENERATESDUAL COX-2/FACTOR XA INHIBITORS WITHENHANCEDCOX-2 SELECTIVITY: AN In-silico DRUGDESIGNSTUDY},
journal = {RASAYAN Journal of Chemistry},
year = {2026},
volume = {19},
number = {04},
pages = {2326--2338},
doi = {10.31788/rjc.2026.1949878}
}
EUVIMED